Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness

被引:309
作者
Rossi, Davide [3 ]
Bruscaggin, Alessio [3 ]
Spina, Valeria [3 ]
Rasi, Silvia [3 ]
Khiabanian, Hossein [4 ,5 ]
Messina, Monica [1 ,2 ]
Fangazio, Marco [3 ]
Vaisitti, Tiziana [6 ,7 ]
Monti, Sara [3 ]
Chiaretti, Sabina [8 ]
Guarini, Anna [8 ]
Del Giudice, Ilaria [8 ]
Cerri, Michaela [3 ]
Cresta, Stefania [3 ]
Deambrogi, Clara [3 ]
Gargiulo, Ernesto [3 ]
Gattei, Valter [9 ]
Forconi, Francesco [10 ]
Bertoni, Francesco [11 ]
Deaglio, Silvia [6 ,7 ]
Rabadan, Raul [4 ,5 ]
Pasqualucci, Laura [1 ,2 ,12 ,13 ]
Foa, Robin [8 ,14 ]
Dalla-Favera, Riccardo [1 ,2 ,12 ,15 ,16 ]
Gaidano, Gianluca [3 ]
机构
[1] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA
[2] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA
[3] Amedeo Avogadro Univ Eastern Piedmont, Dept Clin & Expt Med, Div Hematol, Novara, Italy
[4] Columbia Univ, Dept Biomed Informat, New York, NY 10032 USA
[5] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA
[6] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy
[7] Univ Turin, Human Genet Fdn, Turin, Italy
[8] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Div Hematol, Rome, Italy
[9] Ist Ricovero & Cura Carattere Sci, Ctr Riferimento Oncol, Aviano, Italy
[10] Univ Siena, Div Hematol, I-53100 Siena, Italy
[11] Ist Oncol Svizzera Italiana, Oncol Inst So Switzerland, Bellinzona, Switzerland
[12] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA
[13] Univ Perugia, Inst Hematol, I-06100 Perugia, Italy
[14] Univ Roma La Sapienza, Fdn Eleonora Lorillard Spencer Cenci, Rome, Italy
[15] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA
[16] Columbia Univ, Dept Microbiol & Immunol, New York, NY 10032 USA
关键词
PRE-MESSENGER-RNA; PROTEIN; SPLICEOSTATIN; SURVIVAL; REPEATS; DISEASE; SAPS;
D O I
10.1182/blood-2011-08-373159
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The genetic lesions identified in chronic lymphocytic leukemia (CLL) do not entirely recapitulate the disease pathogenesis and the development of serious complications, such as chemorefractoriness. While investigating the coding genome of fludarabine-refractory CLL, we observed that mutations of SF3B1, encoding a splicing factor and representing a critical component of the cell spliceosome, were recurrent in 10 of 59 (17%) fludarabine-refractory cases, with a frequency significantly greater than that observed in a consecutive CLL cohort sampled at diagnosis (17/301, 5%; P = .002). Mutations were somatically acquired, were generally represented by missense nucleotide changes, clustered in selected HEAT repeats of the SF3B1 protein, recurrently targeted 3 hotspots (codons 662, 666, and 700), and were predictive of a poor prognosis. In fludarabine-refractory CLL, SF3B1 mutations and TP53 disruption distributed in a mutually exclusive fashion (P = .046). The identification of SF3B1 mutations points to splicing regulation as a novel pathogenetic mechanism of potential clinical relevance in CLL. (Blood. 2011;118(26):6904-6908)
引用
收藏
页码:6904 / 6908
页数:5
相关论文
共 25 条
[11]   Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA [J].
Kaida, Daisuke ;
Motoyoshi, Hajime ;
Tashiro, Etsu ;
Nojima, Takayuki ;
Hagiwara, Masatoshi ;
Ishigami, Ken ;
Watanabe, Hidenori ;
Kitahara, Takeshi ;
Yoshida, Tatsuhiko ;
Nakajima, Hidenori ;
Tani, Tokio ;
Horinouchi, Sueharu ;
Yoshida, Minoru .
NATURE CHEMICAL BIOLOGY, 2007, 3 (09) :576-583
[12]   The role of prognostic factors in assessing 'high-risk' subgroups of patients with chronic lymphocytic leukemia [J].
Kay, N. E. ;
O'Brien, S. M. ;
Pettitt, A. R. ;
Stilgenbauer, S. .
LEUKEMIA, 2007, 21 (09) :1885-1891
[13]  
Luke MM, 1996, MOL CELL BIOL, V16, P2744
[14]  
Muller-Hermelink HK., 2008, WHO CLASSIFICATION T, V4th, P180
[15]   Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia [J].
Puente, Xose S. ;
Pinyol, Magda ;
Quesada, Victor ;
Conde, Laura ;
Ordonez, Gonzalo R. ;
Villamor, Neus ;
Escaramis, Georgia ;
Jares, Pedro ;
Bea, Silvia ;
Gonzalez-Diaz, Marcos ;
Bassaganyas, Laia ;
Baumann, Tycho ;
Juan, Manel ;
Lopez-Guerra, Monica ;
Colomer, Dolors ;
Tubio, Jose M. C. ;
Lopez, Cristina ;
Navarro, Alba ;
Tornador, Cristian ;
Aymerich, Marta ;
Rozman, Maria ;
Hernandez, Jesus M. ;
Puente, Diana A. ;
Freije, Jose M. P. ;
Velasco, Gloria ;
Gutierrez-Fernandez, Ana ;
Costa, Dolors ;
Carrio, Anna ;
Guijarro, Sara ;
Enjuanes, Anna ;
Hernandez, Lluis ;
Yaguee, Jordi ;
Nicolas, Pilar ;
Romeo-Casabona, Carlos M. ;
Himmelbauer, Heinz ;
Castillo, Ester ;
Dohm, Juliane C. ;
de Sanjose, Silvia ;
Piris, Miguel A. ;
de Alava, Enrique ;
Miguel, Jesus San ;
Royo, Romina ;
Gelpi, Josep L. ;
Torrents, David ;
Orozco, Modesto ;
Pisano, David G. ;
Valencia, Alfonso ;
Guigo, Roderic ;
Bayes, Monica ;
Heath, Simon .
NATURE, 2011, 475 (7354) :101-105
[16]   The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation [J].
Rossi, Davide ;
Spina, Valeria ;
Deambrogi, Clara ;
Rasi, Silvia ;
Laurenti, Luca ;
Stamatopoulos, Kostas ;
Arcaini, Luca ;
Lucioni, Marco ;
Rocque, Gabrielle B. ;
Xu-Monette, Zijun Y. ;
Visco, Carlo ;
Chang, Julie ;
Chigrinova, Ekaterina ;
Forconi, Francesco ;
Marasca, Roberto ;
Besson, Caroline ;
Papadaki, Theodora ;
Paulli, Marco ;
Larocca, Luigi M. ;
Pileri, Stefano A. ;
Gattei, Valter ;
Bertoni, Francesco ;
Foa, Robin ;
Young, Ken H. ;
Gaidano, Gianluca .
BLOOD, 2011, 117 (12) :3391-3401
[17]   The Prognostic Value of TP53 Mutations in Chronic Lymphocytic Leukemia Is Independent of Del17p13: Implications for Overall Survival and Chemorefractoriness [J].
Rossi, Davide ;
Cerri, Michaela ;
Deambrogi, Clara ;
Sozzi, Elisa ;
Cresta, Stefania ;
Rasi, Silvia ;
De Paoli, Lorenzo ;
Spina, Valeria ;
Gattei, Valter ;
Capello, Daniela ;
Forconi, Francesco ;
Lauria, Francesco ;
Gaidano, Gianluca .
CLINICAL CANCER RESEARCH, 2009, 15 (03) :995-1004
[18]  
Stein H, 2008, WHO CLASSIFICATION T, P233
[19]   Understanding and Managing Ultra High-Risk Chronic Lymphocytic Leukemia [J].
Stilgenbauer, Stephan ;
Zenz, Thorsten .
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2010, :481-488
[20]   SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts [J].
Visconte, V. ;
Makishima, H. ;
Jankowska, A. ;
Szpurka, H. ;
Traina, F. ;
Jerez, A. ;
O'Keefe, C. ;
Rogers, H. J. ;
Sekeres, M. A. ;
Maciejewski, J. P. ;
Tiu, R. V. .
LEUKEMIA, 2012, 26 (03) :542-545